The world’s first fully automated test for faecal calprotectin, EliA™ Calprotectin, has been launched in the UK. This test can differentiate between a variety of functional bowel disorders including Crohn’s disease, ulcerative colitis and irritable bowel syndrome (IBS).
The test allows for faster and more efficient processing of samples than the tests currently used to distinguish between inflammatory bowel disease (IBD) and IBS. Its high sensitivity will enable doctors to diagnose the conditions earlier leading to more effective and successful treatment. The test can also be used to monitor disease activity following the diagnosis allowing it to predict a relapse during remission.
The EliA™ Calprotectin has been shown in clinical trials to outperform blood tests such as CRP and ESR and removes the need for endoscopic procedures, including colonscopy. For further information about arranging a test and diagnosing bowel disorders please click here.